Natriuretic peptides (such as NT-proBNP) are independently associated with prevalent cardiovascular disease (CVD) and future CV events in cross-sectional [29,30] and prospective [31,32,33,34] CKD cohort studies. Here, NPPB is linked to chronic kidney disease.